-umab - ANS-completely humanized moabs
-ximab - ANS-moab combination of human & mouse antibodies
-zumab - ANS-moab humanized, small part of mouse antibody fused w/ human antibody
all-trans retinoic acid (atra) - ANS-tx: aml, aml m3 subtype, apl
growth maturation of promyelocytic blasts and speedy resolution of coagulopathy r/t tx.
Alpha-interferon - ANS-leukocyte-derived. Tx: hairy cellular leukemia, melanoma, chronic
myeloid leukemia, follicular lymphoma, a couple of myeloma, cutaneous t-cell lymphoma
angiogenesis - ANS-growth of recent blood vessels from current vessels. Tumor viability relies
for growth. Vascular endothelial boom elements (vegf) cascade most important component
antibodies - ANS-proteins produced via b-lymphocytes. A part of humoral immunity of adaptive
gadget. Includes immunoglobulins (igG, igA, igM, igE, igD)
beta-interferon - ANS-fibroblast-derived. Tx MS
bevacizumab (avastin) - ANS-vegf inhibitor. Pvt angiogenesis. Tx in relapse/refractory stable
tumors
biotherapy - ANS-modality of tx: sellers that resemble frame's very own defense and
surveillance structures. Can augment/modulate/restore host's immune response, direct
antitumor interest, other organic consequences. Aspect outcomes commonly allergic reaction rx
cancer vaccine - ANS-prophylactic. Given to healthy people (ex: HPV). Stimulate immune
device to attack viruses that could cause cancer. Created by way of acquiring tumor cells,
irradiating them & altering them so immune device acknowledges tumor cells as overseas
chimeric moab - ANS-murine variable & human consistent coupled the usage of recombinant
dna
Colony Stimulating Factors - ANS-ptns that assist hematopoiesis. Decrease myelosuppression,
boost up recovery from bmt, tx infections/parasitic illnesses, assist w/ pancytopenia
cytokines - ANS-merchandise of immune cells to beautify cytotoxic interest of cells and growth
immune response